Clinical Trials Logo

Arthroplasty, Replacement, Hip clinical trials

View clinical trials related to Arthroplasty, Replacement, Hip.

Filter by:
  • Recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06102811 Recruiting - Clinical trials for Arthroplasty, Replacement, Hip

Low Concentration Local Anesthesia Fascia Iliaca Block for Total Hip Arthroplasty

HALF
Start date: October 23, 2023
Phase: N/A
Study type: Interventional

Fascia iliaca compartment block (FICB) is a documented option for postoperative analgesia for total hip arthroplasty (THA) surgery. FICB is demonstrated to be effective in terms of analgesia and opioid requirements decrease, however it causes quadriceps motor weakness. Current available motor sparing techniques are not as effective as FICB for analgesia. Low concentration local anesthetics (LCLA) are used with excellent results for pain control with no or minimum motor block effect, in other scenarios (highlighted in obstetric anesthesia) and techniques (epidural anesthesia, for instance). This study proposes that LCLA-FICB can offer the benefit of peripheral nerve blocks mediated analgesia, while at the same time avoiding motor blockade and muscle weakness. The investigators hypothesize that LCLA-FICB, when compared to conventional high concentration local anesthetics (HCLA) FICB, provides similar postoperative analgesia in the first 24 hours following primary THA, while at the same time preserving quadriceps muscle group strength.

NCT ID: NCT05686915 Recruiting - Clinical trials for Arthroplasty, Replacement, Hip

MARS MRI in Revision THA With a Ceramic Femoral Head and Titanium Sleeve

Start date: December 22, 2022
Phase:
Study type: Observational

Revision total hip replacement using a ceramic head utilizes a titanium sleeve which introduced another articulation into the system that may lead to a local soft tissue reaction. The purpose of this study is to determine the frequency, size and types of MRI documented local tissue reactions in individuals doing well after a revision total hip replacement and ceramic bearing surface that utilizes a titanium sleeve.

NCT ID: NCT05169229 Recruiting - Osteoarthritis, Hip Clinical Trials

Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement.

ABOGRAFT
Start date: April 1, 2022
Phase: Phase 2/Phase 3
Study type: Interventional

Total hip replacement is the most successful treatment modern healthcare can offer patients to regain quality of life. Periprosthetic joint infection (PJI) is the most common and devastating complication after total hip replacement (THR). Between 0.5 to 2% of primary THR (first time hip replacement), and 8-10% of revision THR (replacement of a hip prosthesis) will become infected.1 The introduction of local antibiotics blended into bone cement has led to a reduction in postoperative infection in primary THR by half.2 Unfortunately, cement can't always be used in relevant quantities. The number of primary and revision surgeries of the hip is projected to increase dramatically. Therefore, the need for a feasible infection prophylaxis that is applicable for complex primary and revision THR in addition to antibiotics loaded cement is urgent. Impacted morselized bone allograft is often used in (revision) THR to fill bone defects. Morselized allograft has been used as a carrier for local antibiotic treatment in multiple pilot studies and appears to be an attractive and effective treatment option, both for already infected joints and as a prophylactic measure in high-risk patients (e.g. THR revision surgeries). Nonetheless, a pivotal trial to support its use in THR is lacking. The aim of this pragmatic randomized controlled double blinded drug trial is to investigate whether antibiotic impregnated bone graft (AIBG) decreases the risk of infection after hip arthroplasty compared to controls treated with placebo impregnated bone graft. Patients scheduled for elective THR will be randomized to receive AIBG or a placebo impregnated bone graft. The primary outcome variable will be the number of re-operations due to infections and PJI diagnoses 2 years postoperative.

NCT ID: NCT04960241 Recruiting - Rehabilitation Clinical Trials

Does Rehabilitation After Total Hip Or Knee Arthroplasty Work (DRAW2)

DRAW2
Start date: April 6, 2021
Phase: N/A
Study type: Interventional

Overall frame: The overall or "parent" DRAW-project is a large-scale project run in Denmark that aims to provide substantial level 1A evidence-data related to the question: Does rehabilitation after total hip and knee replacements work? In the DRAW project, the authors challenge the belief that physical rehabilitation is clinically important - and surely better than "no physical rehabilitation". To challenge this belief thoroughly, the DRAW project holds many individual work packages centered around the same question. These work packages will be conducted in collaboration with municipality rehabilitation centers in Denmark so that specific usual care strategies are reflected in the different trials and local clinical relevance is as well as implementation potential are increased.

NCT ID: NCT03863743 Recruiting - Clinical trials for Arthroplasty, Replacement, Knee

Impact of Integrated Care Pathways for Prevention of Post-operative Urinary Retention (POUR)

POUR
Start date: February 5, 2019
Phase: N/A
Study type: Interventional

A prospective randomized control trial will be conducted at Good Samaritan Hospital and TriHealth Evendale Hospital. Subjects will receive total hip or knee surgery and follow-up via standard care at the discretion of the treating physician or the experimental study arm in which all patients will undergo the integrated care pathway.

NCT ID: NCT03849638 Recruiting - Clinical trials for Arthroplasty, Replacement, Knee

Gait Analysis and Gait Training in Patient With Total Hip or Total Knee Replacement

WVPT
Start date: December 6, 2018
Phase: N/A
Study type: Interventional

The main objective of the present study is the evaluation of the kinematic parameters of gait and distribution of the load, recorded thruogh a sensorized treadmill, on lower limbs in patients at 1 year from Total Hip Replacement or Total Knee Replacement. The secondary objective is to evaluate the effects of gait training with biofeedback by means of a sensorized treadmill in patients with asymmetry of the kinematic parameters of the step and of distribution of the load on the lower limbs.

NCT ID: NCT03825029 Recruiting - Clinical trials for Arthroplasty, Replacement, Hip

Pillow Use During Total Hip Arthroplasty

Start date: July 22, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to find out whether placing a pillow between the legs during hip surgery will result in a better aligned hip replacement.

NCT ID: NCT03746925 Recruiting - Clinical trials for Arthroplasty, Replacement, Hip

Comparing Short-term Outcomes After Direct Anterior and SuperPATH Hip Arthroplasty Approaches

Start date: September 7, 2019
Phase: N/A
Study type: Interventional

This study involves comparing the outcomes after using the Direct Anterior Approach (DAA) and the Supercapsular Percutaneously Assisted Total Hip (SuperPATH) approach. These are two approaches to hip replacement that both replace hips without cutting any muscles. DAA approach has been used for many years, but it has a high learning curve and can be difficult for doctors to use, it is however linked with fewer complications when performed by an experienced doctor. SuperPATH is a newer technique which has been shown in studies to be adopted with less complications even during the learning phase. It also shows cost-saving results, showing a reduced length of stay for patients and better 30-day readmission rates. There is pressure on surgeons, from both patients and administration to use techniques that spare tissue, offer early functionality without compromising long-term outcomes. The SuperPATH can meet this benchmark but uptake has been slow, the investigators believe that it is due to the learning curve shown by this approach. The senior surgeon at The Ottawa Hospital is experienced in both techniques, using a trial the investigators can compare the two techniques and help encourage surgeons to change to a procedure that has demonstrated a low complication profile.

NCT ID: NCT03570944 Recruiting - Clinical trials for Arthroplasty, Replacement, Knee

Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol (POWER2)

POWER2
Start date: October 22, 2018
Phase:
Study type: Observational [Patient Registry]

Methods National audit of a 60-day prospective observational cohort in the that the pre-defined postoperative complications at 30 days of follow-up in adult patients electively undergoing hip replacement surgery (HRS) or knee replacement surgery (KRS) with or without a program of Enhanced Recovery (ERAS: Enhanced Recovery after Surgery) with any level of protocol compliance (0-100%) Research Places Spanish Hospitals where these surgical interventions are performed usually Objectives To determine the incidence of Postoperative Complications per patient and procedure, regardless of the degree of adherence to ERAS protocols and its impact on the Hospital Stay and on postoperative complications including 30-day mortality Sample Size For an alpha error of 5% (95% confidence and an accuracy of 3% and estimating a number of patients with complications of 50%, the calculation of sample size yields 3012 patients, although the final sample size may be smaller depending on the proportion of complications detected. Inclusion criteria Patients over 18 undergoing elective HRS or KRS PTC regardless of its affiliation to a ERAS program and the level of compliance with protocol (from 0-100%) Statistical analysis Continuous variables will be described as mean and standard deviation, if it is a normal distribution, or median and interquartile range, if they are not distributed normally. The comparisons of continuous variables are performed by one-way ANOVA or the Mann-Whitney test, depending on proceed A univariate analysis will be carried out to test the factors associated with postoperative complications, hospital stay and death in Hospital. Univariate analyzes and logistic regression models will be constructed Hierarchical multivariate to identify the factors associated in a independent with these results and to adjust the differences in the factors of confusion. The factors will be introduced in the models based on their relationship with the univariate result (p <0.05), the biological plausibility and the low rate of missing data.

NCT ID: NCT02938962 Recruiting - Clinical trials for Arthroplasty, Replacement, Hip

Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X)

VITALITY-X
Start date: October 2016
Phase: Phase 4
Study type: Interventional

The objective of this study is to evaluate and compare the effects of intravenous and topical administration of tranexamic acid during revision hip arthroplasty on blood loss, allogenic blood transfusion rates, length of hospital stay and perioperative complications.